Collection 專利 [0/24] 期刊論文 [110/113] 圖書 [1/1] 會議論文/會議摘要 [10/11] Siblings 余佳益 [17/17] 余冠儀 [40/40] 冷治湘 [61/89] 劉家齊 [45/52] 司徒惠康 [71/72] 吳綺容 [84/84] 周彥宏 [46/58] 宋旺洲 [33/34] 廖經倫 [32/32] 張仲明 [2/2] 張堯 [44/44] 曾凡真 [34/34] 曾才騰 [9/9] 李敏西 [60/64] 杜鴻運 [50/50] 楊采菱 [133/134] 潘建雄 [18/19] 羅秀容 [96/97] 胡勇誌 [23/23] 莊再成 [104/153] 蕭樑基 [158/161] 蘇益仁(2002-2015) [190/195] 許修誌(2005-2010) [1/1] 許素菁 [27/30] 謝鐸源(2006-2014) [20/27] 郭書辰 [139/141] 陳俊宏 [61/62] 陳信偉 [83/110] 陳宜君 [38/38] 陳逢叡 [40/40] 黃明熙 [51/64] 黃盈綺 [6/6] 齊嘉鈺 [46/46] McDonald LC(1998-2000) [12/12] 何曼德(1997-2002) [38/39] 其他 [177/177] 朱清良(2005-2007) [4/4] 梁蘭蘭(1998-2006) [6/6] 黃崑巖(1999-2004) [4/4] Community Statistics 近3年內發表的文件:19(12.75%) 含全文筆數:121(81.21%) 文件下載次數統計 下載大於0次:121(100.00%) 下載大於100次:115(95.04%) 檔案下載總次數:67278(1.26%) 最後更新時間: 2024-11-28 09:35 Top Upload Loading... Top Download Loading... Recent Submissions Boosting DNA vaccine power by lipid... ADAM9 drives the immunosuppressive ... Inhibition of ADAM9 promotes the se... Lipid nanoparticle-encapsulated DNA... ADAM9 drives immunosuppressive envi... A broad-spectrum pneumococcal vacci... Co-delivery of a trimeric spike DNA... A TLR9 agonist synergistically enha... TLR9 and STING agonists cooperative... Recombinant lipidated FLIPr effecti...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-75 of 149. (6 Page(s) Totally) << < 1 2 3 4 5 6 > >> View [10|25|50] records per page

Date	Title	Relation
2016-12	Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer	Oncotarget. 2016 Dec;7(52):85917-85928.
2016-11-09	Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy	Scientific Reports. 2016 Nov 09;6:Article number 36732.
2016-07-29	Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice	Scientific Reports. 2016 Jul 29;6:Article number 30648.
2016-07	Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice	Cancer Letters. 2016 Jul;377(2):126-133.
2016-06	TGF-beta and IL-21 cooperatively stimulate activated CD8 T cells to differentiate into Tc17 cells	Immunology Letters. 2016 Jun;174:23-27.
2016-05-06	A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity	Journal of Controlled Release. 2016 May 6;233:57-63.
2016-05	A toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population	Oncotarget. 2016 May;7(21):30804-30819.
2016-04	Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity	Scientific Reports. 2016 Apr;6:Article number 24199.
2016-02	Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice	Vaccine. 2016 Feb;34(8):1054-1061.
2016-01	A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model	Oncotarget. 2016 Jan;7(1):671-683.
2015-12	Recombinant bacterial lipoproteins as vaccine candidates	Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.
2015-11	Gemcitabine synergistically enhances anti-tumor effects of recombinant immunogen-based cancer immunotherapy	Annals of Oncology. 2015 Nov;26(Suppl. 7):vii79-vii105.
2015-10	Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy	OncoImmunology. 2015 Oct 29;5(3):e1095433.
2015-08-07	Recombinant lipoprotein-based vaccine candidates against C. difficile infections	Journal of Biomedical Science. 2015 Aug 7;22:Article number 65.
2015-07-28	A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms	Scientific Reports. 2015 Jul 28;5:Article number 12578.
2015-06	Recombinant lipoproteins as novel vaccines with intrinsic adjuvant	Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
2015-05-11	佐劑	I483735/2015-05-11
2015-03-06	脂質化腫瘤相關抗原及其免疫治療的組成物及方法	HK1171457/2015-03-06
2015-03	Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: Potential clinical impact	Expert Review of Vaccines. 2015 Mar;14(3):383-394.
2015-02	漫談預防型和治療型子宮頸癌疫苗的現況與未來	院內感染控制雜誌. 2015 Feb;25(1):31-36.
2014-11	Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide	Human Vaccines and Immunotherapeutics. 2014 Nov;10(11):3241-3250.
2014-10-29	脂质化肿瘤相关抗原及其免疫治疗的组成物及方法	ZL201080027969.8/2014-10-29
2014-10	Chemotherapy enhances recombinant lipoimmunogen-based antitumor immunity against cervical cancer	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 637.
2014-08-27	Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice	BioMed Research International. 2014 Aug 27;2014:Article number 878139.
2014-07-30	Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns	Journal of Virology. 2014 Jul 30;88(20):11658-11670.

Showing items 51-75 of 149. (6 Page(s) Totally) << < 1 2 3 4 5 6 > >> View [10|25|50] records per page